Chemical Structure : GABAA receptor agonist CTMB
货号: PC-24988Not For Human Use, Lab Use Only.
CTMB is an allosteric agonist of GABAA receptors, positively modulates GABAA receptors and inhibits voltage-regulated sodium channels (NaVs) to suppress neuronal membrane depolarization.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CTMB is an allosteric agonist of GABAA receptors, positively modulates GABAA receptors and inhibits voltage-regulated sodium channels (NaVs) to suppress neuronal membrane depolarization.
CTMB inhibits the firing activity of interneurons via GABAA receptors and NaVs.
CTMB increases the cell viability and reduces the apoptosis of mechanically scratched HT22 cells through modulation of GABAA receptors.
CTMB (30mg/kg) reduces the area of brain damage and attenuates neurobehavioral deficits at 7 days after traumatic brain injury (TBI).
CTMB (30mg/kg) improves the rats' sensory and motor functions of limbs and attenuates neuronal damage in the subacute phase of traumatic brain injury (TBI).
CTMB mitigates mitochondrial-involved neuronal apoptosis by attenuating the cascading neuro-excitotoxicity of GABAA receptors during the subacute phase of traumatic brain injury (TBI).
CTMB prolonged survival, reduced epilepsy and improved long-term motor ability during the recovery phase of traumatic brain injury (TBI) rats.
分子量 | 234.30 | |
分子式 | C14H18O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Ruijie Yan, et al. Br J Pharmacol. 2025 Jun 24. doi: 10.1111/bph.70117.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright